Filep J G, Földes-Filep E, Rousseau A, Fournier A, Sirois P, Yano M
Department of Pharmacology, Faculty of Medicine, University of Sherbrooke, P.Q., Canada.
Eur J Pharmacol. 1992 Aug 25;219(2):343-4. doi: 10.1016/0014-2999(92)90318-x.
Intravenous injection of endothelin-1 (ET-1, 0.1 and 1 nmol/kg) resulted in a dose-dependent increase in vascular permeability in the coronary circulation of conscious rats. The increase was almost completely abolished by the selective ETA receptor antagonist, BQ-123 (1 mg/kg). The ET-1 analogue, [Trp(For)21]ET-1, which is devoid of the depressor but not the pressor activity, evoked changes in protein extravasation similar to those with ET-1. These data indicate that the permeability effect of ET-1 is mediated through the ETA receptor.